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Corticobasal syndromeMost available pattern recognition methods in neuroimaging address binary classiﬁcation problems. Here, we
used relevance vector machine (RVM) in combination with booststrap resampling (‘bagging’) for non-
hierarchical multiclass classiﬁcation. The method was tested on 120 cerebral 18ﬂuorodeoxyglucose (FDG) posi-
tron emission tomography (PET) scans performed in patients who exhibited parkinsonian clinical features for
3.5 years on average but that were outside the prevailing perception for Parkinson's disease (PD). A radiological
diagnosis of PD was suggested for 30 patients at the time of PET imaging. However, at follow-up several years
after PET imaging, 42 of them ﬁnally received a clinical diagnosis of PD. The remaining 78 APS patients were di-
agnosed with multiple system atrophy (MSA, N = 31), progressive supranuclear palsy (PSP, N = 26) and
corticobasal syndrome (CBS, N = 21), respectively.With respect to this standard of truth, classiﬁcation sensitiv-
ity, speciﬁcity, positive and negative predictive values for PD were 93% 83% 75% and 96%, respectively using bi-
nary RVM (PD vs. APS) and 90%, 87%, 79% and 94%, respectively, using multiclass RVM (PD vs. MSA vs. PSP vs.
CBS). Multiclass RVM achieved 45%, 55% and 62% classiﬁcation accuracy for, MSA, PSP and CBS, respectively. Fi-
nally, a majority conﬁdence ratio was computed for each scan on the basis of class pairs that were the most fre-
quently assigned byRVM. Altogether, the results suggest that automaticmulticlass RVM classiﬁcation of FDG PET
scans achieves adequate performance for the early differentiation between PD and APS on the basis of cerebral
FDG uptake patterns when the clinical diagnosis is felt uncertain. This approach cannot be recommended yet
as an aid for distinction between the three APS classes under consideration.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Computer-aided diagnosis (CAD) integrates data processing,
mathematics and statistics into computerized techniques to maxi-
mize the information that may be extracted from medical imagingRS-FNRS and a grant from the
Research Centre, University of
6 23 16; fax: +32 4 366 29 46.
nc. Open access under CC BY-NC-ND lidatasets. One of the goals of CAD is to assist the clinicians in the dif-
ferential diagnosis between several conditions with overlapping clin-
ical features. This problem is commonly encountered in patients with
a presumed progressive adult-onset chronic neurodegenerative dis-
order, in which the clinical phenotype only fully expressed several
years after the onset of brain damage. Most CAD in this context
addressed a binary classiﬁcation problem i.e., involving the distinc-
tion between two diagnostic classes. One of the challenges of CAD is
multiclass classiﬁcation (Kloppel et al., 2012), which better reﬂects
a situation encountered in routine clinical practice. As compared
with binary classiﬁcation, multiclass classiﬁcation is a more complex
problem and their performances are difﬁcult to compare directly.
Here, we present simple binary and new multiclass classiﬁcation
methods and test their performance for the distinction between dif-
ferent forms of degenerative parkinsonism.cense.
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ness, with muscle rigidity and/or tremor and/or a postural instability
(Gibb, 1988). The most common cause of degenerative parkinsonism in
adults is Parkinson's disease (PD). Much of the difﬁculty in the early
diagnosis of PD is differentiating it from other forms of degenerative par-
kinsonism. A common source of misdiagnosis of PD is atypical parkinso-
nian syndromes (APS) that have a much poorer long-term prognosis
such as multiple system atrophy (MSA), progressive supranuclear palsy
(PSP) and corticobasal syndrome (CBS). In a clinico-pathological study
conducted in a specialist movement disorder service, more than 60% of
cases with a ﬁnal clinical diagnosis of a parkinsonian syndrome other
than PD had their diagnosis changed during the course of their illness.
Of these, 60% were changed from an initial clinical diagnosis of PD
(Hughes et al., 2002; Rajput et al., 1991).
Resting-state cerebral 18ﬂuorodeoxyglucose (FDG) uptake pat-
terns measured using positron emission tomography (PET) has been
recommended by the European Association of Nuclear Medicine Neu-
roimaging Committee for the differentiation between degenerative
parkinsonisms (Varrone et al., 2009) under the assumption that
FDG PET can capture speciﬁc functional and anatomical consequences
of neuropathologic abnormalities speciﬁc of each condition. This is
supported by the demonstration of group differences in regional
FDG uptake between PD, MSA, PSP and CBS (Antonini et al., 1998;
Eckert et al., 2005; Eidelberg et al., 1993; Feng et al., 2008; Ghaemi
et al., 2002; Juh et al., 2004; Klein et al., 2005; Laureys et al., 1999;
Otsuka et al., 1997; Teune et al., 2010). One of the most consistent ab-
normalities at visual inspection and semi-quantitative analyses is a
relative decrease in striatal and frontal lobe tracer uptakes in APS as
compared with PD or normal control populations. While this has
been very informative at the group level, its diagnostic yield has
been lower than expected in the early stages of these disorders be-
cause of overlapping individual regional FDG uptake across groups,
which were often composed of small series of either well established
cases studied with PET after a relatively long disease duration or early
cases but without information on clinical follow-up to ascertain the
initial clinical diagnosis (Garraux et al., 2000; Ghaemi et al., 2002;
Juh et al., 2004; Laureys et al., 1999; Otsuka et al., 1997).
Here, we examined the value of CAD for the distinction between
PD, MSA, PSP and CBS on the basis of cerebral FDG PET. The present
study differs from previous ones by several methodological aspects
with respect to both the population characteristics and analysis
methods. First, to maximize the clinical signiﬁcance of cerebral FDG
PET for distinction between the diagnostic classes under consider-
ation, we included scans performed in the ﬁrst years after symptom
onset (Table 1) at a time when clinical features were outside the
prevailing perceptions for PD. Diagnostic classes were then deﬁned
later by the retrospective application of clinical diagnostic criteria
for PD and APS at follow-up, on average ~8.0 and ~2.8 years after
PET assessment (i.e., standard of truth). Second, a crucial difference
with previous studies is the analysis of neuroimaging data using an
automatic voxel-based multivariate supervised machine learning
method, “Relevance Vector Machine” (RVM) (Tipping, 2001), that
we have previously applied on a binary case for the distinctionTable 1
Demographic and clinical data.
N Gender (F/M) Data at the time of PET assessment
Mean age (years) Mean disea
PD 42 17/25 56.9 ± 10.3 3.6 ± 3.1
MSA 31 18/13 66.0 ± 8.8 3.4 ± 2.9
PSP 26 9/17 69.4 ± 7.3 3.1 ± 2.4
CBS 21 15/6 67.8 ± 7 3.3 ± 2
All classes 120 59/61 63.9 ± 10.2 3.4 ± 2.7
LEDD = L-DOPA equivalent daily dose (Tomlinson et al., 2010).between patients with or without an altered state of consciousness
on the basis of cerebral FDG uptake patterns (Phillips et al., 2011).
We profoundly modiﬁed this method to be suitable for multiclass
classiﬁcation.
Classiﬁcationwas both performed in a binary sense, PDversus all the
APS subcategories pooled into a single class, and in a multiclass sense,
PD and the 3 APS categories considered separately. For multiclass clas-
siﬁcation, pairwise coupling is a popular approach that combines all
comparisons for each pair of classes (Fürnkranz, 2002). Here, we used
a one-versus-one approach involving six binary RVM classiﬁers from
which a single prediction was obtained using an Error-Correcting
Output Code (ECOC) approach (Dietterich and Bakiri, 1995) (see
Section 2.4.3). For cross-validation and assessment of prediction accura-
cy, RVM was combined with bootstrap aggregation (also known as
“bagging”) (Breiman, 1996; Efron and Tibshirani, 1993) and the ﬁnal
RVM class assigned to each FDG PET scanwas deﬁned by the prediction
that received the most votes (see Section 2.4.4).
The ﬁnal class assigned to each FDG PET scan was then compared
with the clinical diagnosis at follow-up to estimate prediction accuracy,
sensitivity, speciﬁcity, positive (PPV) and negative (NPV) predictive
values. The statistical signiﬁcance of RVM classiﬁcation accuracy was
assessed using a permutation testing (see Section 2.4.4). We also com-
pared binary RVM classiﬁcation with the radiological diagnosis of the
nuclear medicine specialist at the time of PET imaging (i.e., for the dis-
tinction between PD and APS).
Finally, from the vote counting in the bootstrap procedure, a
“majority conﬁdence ratio” was estimated for each scan on the
basis of class pairs that were the most frequently assigned by
RVM. This level of conﬁdence was further linked to the PPV (see
Section 2.4.5). We believe that this qualiﬁcation of the classiﬁcation
outcome may provide clinically relevant information at the individ-
ual level for physicians who usually request FDG PET scans as an aid
to solve a multiclass diagnosis problem.
2. Methods
2.1. Subjects
Patients were all referred for cerebral FDG PET at the Cyclotron Re-
search Centre (CRC), University of Liège, or the University Hospital
Center (CHU) of Liège by neurologists because clinical features were
outside the prevailing perceptions for PD. In many cases, no other
speciﬁc diagnosis was mentioned in the PET order form and no stan-
dardized clinical assessment was available in this retrospective study.
The most frequent atypical features at referral were an equivocal clin-
ical response to scheduled L-DOPA administration, prominent axial
symptoms, greater than expected asymmetry of parkinsonian signs,
early falls, or the co-occurrence of other features such as a pyramidal
and/or cerebellar syndrome, limb dystonic posturing, oculomotor ab-
normalities, or severe dysautonomic dysfunction. All subjects includ-
ed in this research protocol gave their written informed consent to
participate in the study; the study protocol was approved by the Eth-
ical Committee of the University of Liège.Last available follow-up
se duration (years) Mean LEDD (mg) Mean disease duration (years)
442 ± 239 11.6 ± 5.1
559 ± 298 6.4 ± 3.9
281 ± 250 5.9 ± 4
164 ± 189 5.9 ± 2.9
386 ± 284 8.0 ± 5.0
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individuals diagnosed with PD, MSA, PSP and CBS at follow-up were
selected for inclusion (Table 1). Patients were included on the basis
of the United Kingdom Parkinson's Disease Society Brain Bank
(UKPDSBB) clinical criteria for PD (Hughes et al., 1992), or the
Neuroprotection and Natural History in Parkinson Plus Syndromes
(NNIPPS) criteria (Bensimon et al., 2009) for MSA or PSP, or the
Lang criteria for CBS (Lang et al., 1994) as reviewed from the medical
records by two movement disorders specialists (GG and AD). In the
MSA group, one, nineteen and eleven patients were clinically classi-
ﬁed as MSA-A, MSA-P and MSA-C, respectively. Detailed clinical
motor and neuropsychological assessments were not available for
all patients. We considered as an exclusion criterion a clinical
follow-up of less than 12 months after PET imaging in order to re-
duce the risk of clinical misdiagnosis. Other exclusion criteria include
any signiﬁcant structural brain abnormalities on CT scan or MRI, and
exposure to drugs that could have caused the clinical ﬁndings. Be-
cause the PET scanner employed for data acquisition at the CRC had
a limited ﬁeld of view in the axial direction (10.31 cm), we also ex-
cluded FDG PET scans when brain coverage in the axial direction
was judged inadequate at visual inspection.
2.2. Imaging data acquisition
Image acquisition was performed between 1993 and 2009 either at
the CRC (N = 87) using a CTI 951 R 16/31 tomograph (CTI, Knoxville,
TN, USA) or at the CHU (N = 33) on a Gemini PET/CT scan (PhilipsMed-
ical Systems) after an intravenous bolus injection of FDG. The proportion
of images acquired on the 2 scanners is the following: overall 72/28%; 74/
26% and72/28% for the PD andAPS, respectively; 74/26%, 68/32%, 62/38%
and 90/10% for the PD,MSA, PSP andCBS respectively. Globally, the scans
from different categories are thus similarly distributed across scanners,
except for the CBS, which also counts the fewer scans over all. Partici-
pants were studied on their usual medications in a quiet wakeful
resting-state, with eyes closed in dimmed ambient light. Head move-
ments were reduced using foam padding and a restraining strap.
2.3. Imaging data processing
After gross manual image reorientation and approximate deﬁni-
tion of the image center point, the PET images were spatially
processed using the Statistical Parametric Mapping toolbox (SPM8,
Wellcome Trust Centre for Neuroimaging, 2008) implemented within
Matlab 7.4.0 (MathWorks, Natick, MA, USA).
All images were spatially normalized onto a population-speciﬁc
FDG PET template created in MNI space, as previously reported
(Phillips et al., 2011), and then spatially smoothed using a 12 mm
FWHM Gaussian kernel (Garraux et al., 2000). To minimize any bias
in the RVM analyses due to differences in brain coverage in the
axial direction, we next created a binary mask image representing
the brain voxels common to all scans. Furthermore, within this
mask, we only considered voxels that had a probability of being
grey matter higher than .33, according to the tissue probability map
provided in SPM8. To account for the variability associated with var-
ious sources of physiological and non-physiological noise inherent
to PET data, intensity normalization of regional tracer uptake to the
global mean activity was applied to each scan prior to their analysis
using a proportional scaling procedure (Friston et al., 1990).
2.4. PET data analysis
2.4.1. Radiological diagnosis
We retrospectively examined the radiological reports of the nucle-
ar medicine specialists who reviewed FDG scans at the time of PET
imaging and computed the number of scans considered as suggestive
of PD and APS.2.4.2. Relevance vector machine (RVM) classiﬁcation
Voxel-based multivariate analysis of FDG PET scans was performed
using a RVM (Tipping, 2001) and lead to ‘pattern recognition’ in the
data. RVM relies on the same principle as “Support Vector Machine”
(SVM) but is framed within a Bayesian framework contrary to SVM
(which is expressed as “maximal margin” problem).
The linear RVMmethod applied here on FDG-PET datawas similar to
that described in Phillips et al. (2011) and allowed the classiﬁcation of
data points, i.e. PET scans, into two classes. This is a so-called supervised
learning approach since the machine is trained on a training dataset
where the true class membership of each data point is provided. Brieﬂy,
the RVM belongs to a set of sparse machine-learning approaches that
builds a classiﬁcation/regression function from a weighted linear com-
bination of kernel functions, in which the weights are tuned during
the learning phase to produce an optimal classiﬁcation of the training
data (Krishnapuram et al., 2005). Sparse means that the weight esti-
mates are encouraged during the learning process to be either high or
exactly zero, to make the model more parsimonious, efﬁcient to run,
to avoid over-ﬁtting, and to improve generalization capacity. Based on
the output weights, a posterior class-probability of a new test image
can be estimated (Tipping, 2001). This posterior class-probability can
eventually be thresholded (usually at 0.5 for balanced data set) to pro-
vide a class-prediction on the test instance.
Here, RVM was used for the distinction between PD and APS in bi-
nary and multiclass situations, when the 3 subcategories (MSA, PSP
and CBS) of APS are considered. Practically, this multiclass RVM relied
on a set of 6 pairwise RVM's for the one-to-one classiﬁcation of each
pair of classes (PD vs. MSA, PD vs. PSP, PD vs. CBS, MSA vs. PSP,
MSA vs. CBS, and PSP vs. CBS) and the output of the 6 classiﬁcations
were recombined afterwards (see Section 2.4.3). We assessed the
performance of both multiclass RVM and conventional binary RVM.2.4.3. Bootstrap resampling (“bagging”)
For cross-validation and assessment of prediction accuracy, RVM
was combined with bootstrap aggregation (also known as “bagging”)
(Breiman, 1996; Efron and Tibshirani, 1993). In statistics, resampling
techniques are used to validate models and to assess their statistical
accuracy by using random subsets (bootstrapping cross-validation)
(Efron and Tibshirani, 1986; Efron and Tibshirani, 1995). Bootstrap
resampling consists in uniformly sampling objects from a dataset,
with replacement. “Bags” of data were created by random sampling,
with replacement, from the original pool of training data. Here, we
performed 100 iterations, involving a new bootstrap sample per iter-
ation. At each iteration, a ﬁxed number of PET images were randomly
sampled (with replacement) from each category to form the training
set, used to build the RVM models (Fig. 1). This ﬁxed number was
computed as the number of images in the class with the smallest
sample size and therefore depended on whether the RVM analysis
was binary (i.e., PD versus APS, 42 images of each class selected) or
multiclass (i.e., PD, MSA, PSP and CBS classes considered, 21 images
of each category selected). The remaining images formed the test
set, which was used to test the built RVM models. Note that, because
of the replacement step in bagging, even if N images are randomly
sampled from a group of N images, some images will be selected mul-
tiple times in the training set and there will remain on average .37*N
not-selected images to form the test set. As a result of this division be-
tween training and test sets, the training set is balanced between
classes while the test set shows similar proportions of each class as
in the whole data set. The bootstrap sample considered here can
therefore be considered as stratiﬁed (Efron and Tibshirani, 1993).
For the binary RVM analysis (PD vs. APS), at each bootstrap
resampling, an RVM is trained with the training set. Then the trained
RVM classiﬁer is applied on the scans in the test set and the class
assigned to each test-scan is obtained by thresholding its posterior
class-probability at 0.5 (since the training set is balanced).
…..
Testing dataset
(unknown labels)
Whole dataset
PSP label (N=26)
CBS label (N=21)
…..
…..
…..
…..
PD label (N=42)
MSA label (N=31)
Training dataset
PSP label (N<21)
CBS label (N<21)
…..
…..
…..
…..
PD label (N<21)
MSA label (N<21)
remaining scans
21 random 
samples  
with 
replacement 
for each 
class
- trained RVM
- discriminant image
Training  
PD vs. MSA
Training  
PD vs. PSP
Training  
PD vs. CBS
Training  
MSA vs. PSP
Training  
MSA vs. CSB
Training  
PSP vs. CBS
- trained RVM
- discriminant image
- trained RVM
- discriminant image
- trained RVM
- discriminant image
- trained RVM
- discriminant image
- trained RVM
- discriminant image
6 trained 
RVM’s
- 6 posterior class 
probabilities [0 1]
- class prediction 
based on ECOC
Fig. 1. Bootstrap resampling with replacement (“bagging”). At each iteration, the whole FDG-PET dataset was split into training and test sets. A prediction was assigned to each test
instance by each of the six trained RVM models. A single prediction (PD, MSA, PSP or CBS) was obtained from the six RVM models using an Error-Correcting Output Code (ECOC)
approach (Dietterich and Bakiri, 1995).
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multiclass classiﬁcation problem as class prediction relies on the out-
put of 6 pairwise RVM classiﬁers (Fürnkranz, 2002). Here, this issue
was addressed using an Error-Correcting Output Code approach
(ECOC) (Dietterich and Bakiri, 1995). In the ECOC scheme, each
class is represented by a code-word of length n, n being the number
of pairwise classiﬁcations performed, and each character of the
code-word is the expected output of the corresponding binary classi-
ﬁer for the speciﬁc class (Inline Supplementary Table S1). Given a test
image, the six binary RVM's (PD vs. MSA, PD vs. PSP, PD vs. CBS, MSA
vs. PSP, MSA vs. CBS, PSP vs. CBS) return 6 probabilistic values
forming a test-word that is then compared to the four code-words.
Eventually, the class whose code-word leads to the smallest distance
is picked as the predicted class for the test image (Hassabis et al.,
2009; Mourao-Miranda et al., 2006). Given the probabilistic nature
of an RVM output, the distance between the test-word and each
code-words is estimated as the sum of absolute difference between
the code-word characters and output from each RVM, i.e. using an
L1 norm (Schrouff et al., 2012).
At each resampling of the bootstrap procedure of both binary and
multiclass RVM, each test instance is thus assigned to a single class.
So, after the 100 bagging iterations, we were able to rank the predic-
tions for each scan according to the proportion of the respective votes
received. The ﬁnal RVM class assigned to each FDG PET scan was de-
ﬁned by the prediction that received the most votes, i.e. the most
often prediction assigned over the iterations where the scan appeared
in the test set (Table 2).
Inline Supplementary Table S1 can be found online at http://dx.
doi.org/10.1016/j.nicl.2013.06.004.
2.4.4. RVM classiﬁcation accuracy
Multiclass and binary RVMwere both considered in all analyses de-
tailed in this section. Classiﬁcation accuracy estimates were assessed bycomparing the class assigned to each FDG PET scan with the stan-
dard of truth given by the diagnosis at the last available follow-up
(Table 2).
We computed prediction accuracy estimates. Overall accuracy was
deﬁned as the number of scans correctly classiﬁed over the total
number of scans, while balanced accuracy was the mean of the
class-speciﬁc accuracies. By deﬁnition, class accuracy is the propor-
tion of images pertaining to each class that are correctly classiﬁed.
Here, class accuracy estimates were summarized in a confusion ma-
trix where each row represents the instances in a predicted class
and each column the instances in a diagnostic class. From the confu-
sion matrix, we computed discrimination measures: sensitivity, spec-
iﬁcity, positive and negative predictive values (PPV and NPV) for PD
as compared with APS. In multiclass RVM, the PPV was estimated,
for each class, as the ratio between the number of scans correctly clas-
siﬁed in a class and the total number of scans classiﬁed in that class.
The NPV was estimated as the ratio between the number of scans cor-
rectly not classiﬁed in a class and the total number of scans not clas-
siﬁed in that class.
We used a permutation approach to make statistical inferences on
prediction accuracy under the null hypothesis of classiﬁcation at chance
level. The following three steps were repeated 1000 times: i) class labels
(PD/APS or PD/MSA/PSP/CBS for the binary or multiclass RVM, respec-
tively) were randomly permuted between all scans, ii) the (binary or
multiclass) classiﬁer was trained, with bootstrap sampling, on the basis
of these random labels, and iii) the resulting accuracy was calculated
for current label permutation. The observed classiﬁcation accuracy
obtained with the original diagnostic labels was then compared to the
histogram of accuracy values over permutations. A p-value was derived
as the ratio between the number of permutations with accuracy higher
or equal than the original accuracy, and the number of permutations.
This p-value is thus an estimation of the probability that a random per-
mutation of the labels leads to higher classiﬁcation accuracy than the
Table 2
Bootstrap resampling procedure (multiclass RVM).
Bag #1 Bag #2 Bag #3 Bag #n-2 Bag #n-1 Bag #n Vote counting Standard of
truth (SOT)
RVM prediction
accuracy
Majority conﬁdence ratio
Vote #1 Vote #2 Vote # 3 Vote #n-2 Vote #n-1 Vote #n Majority vote? Clinical diagnosis Majority vote = SOT?
Scan #1 PD – MSA PD PD – NPD = 32
NMSA = 2
NPSP = 1
NCBS = 0
PD 1 (32 − 2) / 35 ∗ 100 = 85%
Scan #2 PD PSP – MSA MSA PD NPD = 13
NMSA = 9
NPSP = 5
NCBS = 4
MSA 0 (13 − 9) / 31 ∗ 100 = 13%
· · · · · · · · · · ·
· · · · · · · · · · ·
· · · · · · · · · · ·
Scan #120 PD PSP CBS – – PSP NPD = 4
NMSA = 3
NPSP = 13
NCBS = 10
CBS 0 (13 − 10) / 30 ∗ 100 = 10%
– = scan included in the training set and not in the test set in this bootstrap sample.
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mean “classiﬁcation accuracy” over the 1000 permutations.
Finally, RVM classiﬁcation accuracy was also compared with the
radiological diagnosis made by the nuclear medicine specialist at
the time of PET on the basis of clinical and imaging features. This anal-
ysis was restricted to the differentiation between PD and APS, since
this best matched the clinical question under consideration. The
RVM classiﬁcation and radiological diagnostic could be in agreement
(correctly or incorrectly) or disagreement, with one correct and the
other incorrect (4 possible scenarios). We estimated the proportion
of scans in each scenario when PD and APS patients are considered
separately and pooled together.2.4.5. Diagnostic reliability
In addition to the methods presented in the previous section in-
vestigating RVM prediction accuracy, we estimated a classiﬁcation
‘majority conﬁdence ratio’ measure that could also be delivered to
the clinicians to assist them in their diagnostic process. This addition-
al measure takes advantage of the bagging procedure and is comput-
ed on the basis of the two classes that were the most frequently
assigned by RVM over baggings.
For each scan, a classiﬁcation ‘majority conﬁdence ratio’ was
computed as the ratio between the difference in the number of
votes between the two classes receiving the largest number of
votes, and the number of times the scan was picked in the test set
(i.e., total number of votes), expressed in percent (Table 2). In
other words, a value of 100% indicates that each time the scan was
picked in the test set it was classiﬁed in the same class. Conversely,
the smaller the value, the more variables were the votes across the
bootstrap samplings.
Then, we examined how the PPV varied according to this majority
conﬁdence ratio. For a given threshold on conﬁdence level tc, we
estimated the corresponding PPV(tc) by counting the number of
scans – total and correctly classiﬁed in a class – with a conﬁdence
value above tc. tc was varied from 0% to 90% by steps of 10%. One
would expect that the higher conﬁdence level, the higher is the PPV
value (i.e., fewer false positives) and the lower is the number of
scans considered for computing the corresponding PPV. Finally a
correlation coefﬁcient (with its associated p-value) was calculated
between the tc level considered and the observed PPV(tc). This cor-
relation coefﬁcient is helpful in assessing the information conveyed
by the ‘majority conﬁdence ratio’ with respect to the PPV of RVM
classiﬁcation.2.4.6. Relevance maps
With voxel-based multivariate image classiﬁcation methods, all
voxels potentially contribute to the classiﬁcation but their respective
contribution is not equal. Given a trained RVM with a linear kernel,
this relevance value varies from voxel to voxel and can be summarized
as a discriminant image or “relevance map”. A relevance map thus rep-
resents the joint pattern of all voxels whose relative level of activity
allows the discrimination between the two classes of data under consid-
eration. Two networks can generally be identiﬁed when class A is com-
pared to class B: an excess (deﬁcit) network corresponding to regions
displaying positive (negative) relevance, indicating that a relative in-
crease in FDG uptake in these regions increases the likelihood of classi-
ﬁcation in class A (class B).
A relevance map was created at each resampling of the bootstrap
procedure giving in total 100 images for each binary RVM model
(Fig. 1). Consistency in the discriminant patterns over resamplings
was assessed by normalizing the weight obtained across the 100 bags.
This was done in a standardized 1st moment sense, i.e. the mean of
the 100 weights (at each voxel) divided by its standard deviation.
By convention here, the excess and deﬁcit networks in discriminant
standardizedmaps were represented by positive and negative Z values,
respectively. The largest (absolute) values in standardized maps high-
light brain regions where FDG uptake levels contribute themost consis-
tently (over the 100 bootstrap samplings) to the overall distinction
between the two classes under consideration. Conversely, voxels with
a Z standardized value close to zero have a relatively variable (across
the bootstrap samplings) contribution to the distinction between the
two diagnostic classes under consideration.
Note that these standardizedmaps cannot be thresholded as is usual-
ly done in univariate analysis (statistical parametric maps) because they
reﬂect the distributed nature of amultivariate analysis. Nevertheless, in a
proper cross-validation scheme, they could be used for feature selection
such as “recursive feature elimination” (De Martino et al., 2008).
3. Results
An estimation of the computational cost of testing, training and
validating the machines is provided in the supplementary material.
3.1. RVM classiﬁcation accuracy
3.1.1. Binary RVM analysis
On average, scans from PD and APS classes were incorporated in
the training dataset, as expected (Breiman, 1996), in 64% and 42%
Table 3
Confusion matrix derived from bootstrap aggregation (bagging) in binary RVM.
RVM classiﬁcation Diagnostic classes (SOT) PPV & NPV
PD APS
PD 39 13 .75
APS 3 65 .96
Class accuracy (p-value) .93 (0.0) .83 (0.0)
The table shows class accuracies (with the associate p-value) and positive/negative
predictive values (PPV and NPV). SOT = standard of truth. The number of scans cor-
rectly classiﬁed in each class is indicated in bold.
Table 5
Confusion matrix derived from bootstrap aggregation (bagging) in multiclass RVM.
RVM classiﬁcation Diagnostic classes (SOT) PPV/NPV
PD MSA PSP CBS
PD 38 6 2 2 .79/.94
MSA 1 14 5 1 .67/.83
PSP 1 7 14 5 .52/.87
CBS 2 4 5 13 .54/.92
Class accuracy (p-value) .90 (0.0) .45 (.149) .55 (.067) .62 (.025)
The table shows class accuracies (with the associate p-value) and positive/negative
predictive values (PPV and NPV). SOT = standard of truth. The number of scans cor-
rectly classiﬁed in each class is indicated in bold.
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are 87% and 88% respectively. The confusion matrix obtained is
shown in Table 3, which also includes the class accuracies as well
as PPV and NPV. Classiﬁcation accuracy estimates are signiﬁcantly
(p b 0.05) above chance levels (0.46 and 0.53 for the PD and APS
classes respectively).
The comparison between RVM classiﬁcation and radiological diag-
nosis accuracy is summarized in Table 4.
In comparison with the ﬁnal clinical diagnosis at the last follow-up
(i.e. standard of truth), RVM and clinical diagnoses were correctly in
agreement formost (74%) of the patients and both of them are jointly in-
correct for only a few scans (3 out of 120). They disagreed in 24% of the
scans (28 patients out of 120). Strikingly, at visual inspection, 36% of the
PET scans from patients who received a ﬁnal clinical diagnosis of PD at
the last follow-up were considered not suggestive of PD by the nuclear
medicine specialist. On the other hand, RVM tended to slightly underdi-
agnose APS (16%) as compared with the radiological evaluation.
3.1.2. Multiclass RVM analysis
On average, scans from PD, MSA, PSP and CBS classes were incorpo-
rated in the training dataset in 39%, 50%, 56%, and 64% of bootstrap sam-
ples, respectively. Overall and balanced accuracies are 66% and 63%
respectively. The confusion matrix obtained is shown in Table 5,
which also includes the class accuracies as well as PPV and NPV. Classi-
ﬁcation accuracywas signiﬁcantly (p b 0.05) above chance levels (0.26,
0.25, 0.25 and 0.23 for the PD, MSA, PSP and CBS classes respectively)
for the PD and CBS classes only. On the one hand, PD scans are accurate-
ly classiﬁed and those misclassiﬁed seem evenly distributed between
the three APS classes (MSA, PSP and CBS). On the other hand, accuracy
is lower for the individual MSA/PSP/CBS classiﬁcation but most
misclassiﬁed APS scans are distributed among themselves: only 10 out
of 37 misclassiﬁed MSA/PSP/CBS scans were classiﬁed into the PD class.
Further information related to the scanner used to acquire the FDG
PET images (at CRC or CHU) canbe found in the supplementarymaterial.
3.2. Diagnostic reliability
Fig. 2 shows the PPV as a function of the majority conﬁdence ratio,
for the binary andmulticlass cases. The correlation coefﬁcients betweenTable 4
Accuracy of RVM classiﬁcation and the radiological diagnosis at the time of PET.
42 PD
patients
78 APS
patients
Total 120
patients
Correct agreement 26 (62%) 63 (81%) 89 (74%)
Incorrect agreement 2 (5%) 1 (1%) 3 (3%)
Correct RVM, incorrect radiological 13 (31%) 2 (3%) 15 (13%)
Correct radiological, incorrect RVM 1 (2%) 12 (15%) 13 (11%)
The table summarizes the accuracy of binary RVM classiﬁcation and radiological diag-
nosis, for the two diagnostic classes (PD and APS) together (last column) or separately.
RVM classiﬁcation and the radiological diagnostic could be in agreement (correctly or
incorrectly) or disagreement, with one correct and the other incorrect with respect
to the standard of truth (SOT) given by the clinical diagnosis at the last available
follow-up several years after PET assessment (Table 1).the PPV and conﬁdence level are .98 (p b 10−6) and .93 (p b 10−4) for
the binary case (PD and APS classes respectively) and .97 (p b 10−5),
.95 (p b 10−4),− .53 (p = .12) and .71 (p = .02) for the multiclass
case (PD, MSA, PSP and CBS classes respectively).
For the binary case, the PPV of both PD and APS (almost) mono-
tonically increase as a function of the conﬁdence level. Given the
curves and signiﬁcant correlation coefﬁcients, the classiﬁcation conﬁ-
dence estimated for each scan appeared to be a good indicator of PPV.
Nevertheless this majority conﬁdence ratio is not a direct estimator of
the PPV value as both sets of values varies over relatively different
scales, for example a majority conﬁdence ratio of 50% corresponds
to an 80% PPV for the PD class.
For the multiclass case, the PPV also increases regularly with the
level of conﬁdence for the PD, MSA and CBS classes. As in the binary
case, the classiﬁcation conﬁdence seems a good indicator of PPV for
these three classes. For PSP, several scans were misclassiﬁed as PSP
with a relatively high conﬁdence level (>60%). This leads to a maxi-
mum of PPV (67%) above 40% conﬁdence and a drop of the PPV value
for higher conﬁdence level (down to 33% for conﬁdence above 80%).
In both binary and more particularly multiclass cases, the ‘dips’ in
the PPV curves are due to the low number of scans correctly/incorrectly
classiﬁed over the whole scale of conﬁdence values (from 0 to 100%).
With fewer bins (conﬁdence levels above 0, 20, 40, 60 and 80%) the
curves have similar proﬁle but are smoother.
3.3. Relevance maps
3.3.1. Binary RVM analysis
RVM identiﬁed two types of discriminating patterns between PD
and APS, as seen on the standardized map shown on Fig. 3A. The ex-
cess network (EN) mainly encompassed the ventral part of upper
brain stem, medial thalami, ventral striatum, head of caudate nuclei,
medial temporal areas, middle and anterior cingulate areas, medial
frontal cortex including the pre-supplementary motor area (SMA),
insula cortex, superior and caudal aspects of dorsal frontal cortices.
The deﬁcit network (DN) included the lateral aspects of both thalami,
posterior associative areas mainly in medial parietal areas and poste-
rior cingulate gyri, lateral temporal and occipital areas, as well as the
inferior part of the frontal lobe including subgenual, orbitofrontal
and inferior lateral prefrontal cortices.
3.3.2. Multiclass RVM analysis
Discriminant standardized maps for the multiclass RVM analysis
are shown in Fig. 3B (PD vs. MSA, PSP, and CBS) and Inline Supple-
mentary Fig. S1 (comparison between APS subtypes).
Inline Supplementary Fig. S1 can be found online at http://dx.doi.
org/10.1016/j.nicl.2013.06.004.
- PD vsMSA: the main constituting areas of the ENwere the cerebel-
lum (both vermis and cerebellar hemispheres), medial thalami,
posterior putamen, caudate nuclei, the hypothalamic region, lim-
bic areas (anterior and middle cingulate regions and insula corti-
ces), caudal and lateral aspects of frontal lobes. The DN network
Fig. 2. Positive predictive values as a function of the majority conﬁdence ratio. Variation of positive predictive value (PPV) when only scans above a classiﬁcation conﬁdence thresh-
old are counted (total number and number of correctly classiﬁed): the threshold tc of conﬁdence level is varied from 0 to 90% by steps of 10%.
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tive cortices and inferior frontal lobes.
- PD vs PSP: the EN mainly comprised upper brain stem, medial
thalami, caudate nuclei, ventral striatum, insula cortex, medial
frontal areas (including the subgenual and anterior cingulate cor-
tices) and both lateral and medial aspects of caudal frontal lobes.
The DN included the lateral thalami, posterior associative cortices;
the DN also encompassed middle and inferior frontal cortex.
- PD vs CBS: the EN mainly inxcluded upper brain stem, medial
thalami, putamen, caudate nuclei, insula cortices, medial frontal
cortex, and caudal lateral frontal areas. As in the comparison
with MSA and PSP, the DN strongly involved posterior associative
cortices and middle and inferior frontal areas.
- MSA vs PSP: the EN encompassed medial temporal areas and ros-
tral medial frontal areas including the presupplementary motor
area and anterior cingulate cortex. Bilateral caudal lateral frontal
cortices and lateral parietal cortices were also part of the EN. Bilat-
eral thalami, posterior putamen and cerebellum were the main
constituting parts of the DN along with perirolandic regions, and
posterior associative cortices.
- MSA vs CBS: the EN encompassed lenticular nuclei, insula cortex,
and frontal areas mainly in their medial aspects. The DN mainly
encompassed the cerebellar vermis and globi pallidi, bilaterally.
- PSP vs CBS: the EN mainly included cerebellum, thalamus and bi-
lateral lenticular nuclei; at the cortical level, the EN was mostly
composed of caudal frontal areas and primary sensori-motor cor-
tices, bilaterally; the DN encompassed upper brainstem, medial
thalamus and globus pallidum, bilaterally.
4. Discussion
We have presented here an original supervised machine learning
method for both binary and multiclass classiﬁcation of neuroimaging
datasets of a single modality by using RVM in combination with
booststrap resampling (bagging). The method is fast, requires little
user intervention and could be easily extended to a clinical setting.
Generalizability and accuracy were investigated on the early distinc-
tion between PD and three other forms of degenerative parkinsonism
on the basis of cerebral FDG uptake pattern measured with PET. The
clinical question under consideration is not trivial since PD is associ-
ated with a much better long-term prognosis than APS. At the time
of PET imaging, all 120 participants exhibited parkinsonian features
that were outside the prevailing perception for PD. The radiological
diagnosis based on visual inspection of FDG data by a nuclear medi-
cine specialist at the time of PET was PD and APS for 30 and 90scans, respectively. However, at follow-up on average 8 years after
PET imaging, 42 patients ﬁnally received a clinical diagnosis of PD.
The remaining 78 APS patients were diagnosed with MSA (N = 31),
PSP (N = 26) and CBS (N = 21), respectively. In comparison with
this standard of truth, the sensitivity (accuracy), speciﬁcity, PPV and
NPV of the radiological diagnosis for PD as compared with APS were
64%, 96%, 90% and 83%, respectively.
RVM prediction sensitivity, speciﬁcity, PPV and NPV for PD were
93% 83% 75% and 96%, respectively using binary RVM (PD vs. APS;
Table 3) and 90%, 87%, 79% and 94%, respectively, using multiclass
RVM (PD vs. MSA vs. PSP vs. CBS; Table 5). Multiclass RVM achieved
45%, 55% and 62% classiﬁcation accuracy for, MSA, PSP and CBS, re-
spectively. Prediction accuracy for PD was signiﬁcantly better than
prediction at chance level estimated from random permutations in
both binary and multiclass RVM. Classiﬁcation accuracy was also sig-
niﬁcantly above chance level for the APS class and CBS using binary
and multiclass RVM, respectively. Altogether, the results suggest that
automatic multiclass RVM classiﬁcation of FDG PET scans is suitable
for CAD between PD and APS but cannot be recommended yet as an
aid for distinction between the three APS classes under consideration.
RVM classiﬁcation performance should improve by feeding the classi-
ﬁer with qualitative (i.e., motor symptom asymmetry, oculo-motor
disturbances…) and quantitative (i.e., L-DOPA responsiveness…) clin-
ical features (Warr and Walker, 2012). However, the combination of
different modalities in a single model is not immediate and still re-
quires important methodological developments (using for example a
“Multi-kernel learning” technique as in Gonen and Alpaydin, 2011).
We compared binary RVM classiﬁcation with the radiological
diagnosis (PD or APS) made by nuclear medicine specialists who
reviewed imaging features at the time of PET (Table 4). RVM classiﬁ-
cation and radiological diagnosis were frequently in agreement (74%
and 3% for correctly and incorrectly classiﬁcation) but when they
disagreed they did so differently: PD and APS misclassiﬁcation oc-
curred more frequently using radiological and RVM classiﬁcation, re-
spectively. This suggests that there may have been a tendency
amongst nuclear medicine specialists to place too much emphasis
on subtle atypical FDG PET imaging features for PD and to overdiag-
nose APS. This is perhaps not unreasonable since patients were
referred for clinical features that were felt atypical for PD. Alternative-
ly, this may also suggest a more variable FDG uptake pattern in PD
than formerly recognized in our speciﬁc group of patients. This vari-
ability is therefore used by RVM to build more sensitive (albeit less
speciﬁc) classiﬁcation models for PD.
RVM prediction accuracy estimates for PD as compared with the
three other classes were similar to those reported by Tang et al.
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Fig. 3. Discriminant standardized maps between PD and APS. Unthresholded discriminant standardized map computed from the binary (A) and multiclass (B) RVM analyses com-
paring PD and APS classes. The color scale represents the standardized values computed on the basis of the 100 discriminant images created during bootstrap resampling (Fig. 1). By
convention here, the excess network (EN) where FDG uptake is relatively increased in the PD class as compared with the APS class is represented by positive standardized values
while relative deﬁcits are represented by negative standardized values. Most voxels have a standardized value close to zero and therefore their contribution to the distinction be-
tween the two diagnostic classes under consideration is rather variable across the bootstrap samplings. The discriminant maps are displayed on representative axial (Z = 0, 20 and
40 mm), and sagittal (X = 0 mm) slices through a standard T1-weighted MRI in stereotactic space. Z and X values at the bottom indicate the distance (in mm) of the image from
the axial plane through the anterior and posterior commissures and from the parasagittal plane through the midline, respectively. L = Left.
890 G. Garraux et al. / NeuroImage: Clinical 2 (2013) 883–893(2010) in the only comparable FDG PET study despite profound
methodological differences (Tang et al., 2010). In that study, class
prediction was based on a logistic regression model involving three
predictor variables that quantiﬁed the individual expression of meta-
bolic covariance patterns related to PD, MSA, and PSP classes. These
patterns were deﬁned by voxel-based principal component analyses
(PCA) that, by deﬁnition, seek the directions of greatest variation in
the FDG PET datasets (Spetsieris et al., 2009). Another importantmethodological difference is the hierarchical (two-level) binary clas-
siﬁcation approach used by Tang et al (2010): the distinction between
PD and APS was addressed at the ﬁrst level while the second level in-
volved the distinction between the two APS classes under consider-
ation, namely MSA and PSP. Furthermore, in that study, ~14% of the
scans that were classiﬁed as indeterminate at the ﬁrst level (13/96
and 11/71 in the PD andAPS classes, respectively) on the basis of criteria
deﬁned on the same dataset were discarded from the accuracy analysis.
891G. Garraux et al. / NeuroImage: Clinical 2 (2013) 883–893This double dipping procedure employed by Tang et al. (2010) (i.e.,
using non-independent samples for deﬁning and applying a given
threshold) is questionable because it introduces some circularity
(Kriegeskorte et al., 2009). Here, all scans were considered for comput-
ing prediction accuracy estimatesmaking difﬁcult a strict comparison of
classiﬁcation performance between studies. Both the present approach
and that proposed by Tang et al. (2010) should be validated on an inde-
pendent sample. Furthermore a potential confound common to both
studies is the difference in mean age at the time of PET assessment,
which was signiﬁcantly lower in PD than in APS patients (Table 1). As
in the study of Tang et al. (2010), the present data did not allow classi-
ﬁcation accuracy to be statistically adjusted for age effects (Miller and
Chapman, 2001). A younger age at PET assessment in the PD class
than in the three other classes clearly represents a limitation of the
RVM classiﬁers built here.
Here, we computed an additional quantitative measure that could
also be delivered to the clinicians to assist them in their diagnostic
process. This classiﬁcation majority conﬁdence ratio measure takes
advantage of the bagging procedure and was computed on the
basis of the two most frequent votes assigned to each scan over bag-
ging (Table 2). The procedure used to compute this majority conﬁ-
dence ratio in multiclass RVM provided a qualitative outcome
measure that could be delivered to the clinicians, as for the binary
case. Speciﬁcally in the multiclass case, the majority conﬁdence
ratio will reﬂect how the votes are distributed among the
runner-up classes. For example, consider two scenarios where the
votes are distributed as 70–10–10–10% and 70–30–0–0%. In both
cases, the winning class has the same majority of votes (70%) but
the majority conﬁdence ratio is 60% and 40%, respectively. With the
70–30–0–0% votes, the runner-up category is “close” (30% compared
to 70%) and could potentially be a valid alternative, while for the 70–
10–10–10% votes none of the other classes accumulate relatively
large number of votes, making the other classes less plausible. This
feeling is reﬂected by the lower majority conﬁdence ratio (40%)
compared to that (60%) of the other voting scenario. The majority
conﬁdence ratio could also be interpreted as an estimate of the dilu-
tion of the votes among the non-winning classes.
One could also look at the class pairs that were the most frequently
assigned to each scan over bagging. In our data, PD and MSA were the
most frequent class pairs assigned to the PD patient' scans (data not
shown). This suggests that PD and MSA are frequently considered as
rival classes by multiclass RVM, an observation consistent with results
of clinico-pathological correlations (Hughes et al., 2001; Wenning et
al., 1995). In the three APS classes, the closest rival class was another
APS class. In other words, APS misclassiﬁcation is more likely to occur
between APS classes than between PD and APS.
The majority vote ratio was linked to the PPV: a higher ratio value
was generally associated with a higher PPV (Fig. 2). The majority con-
ﬁdence ratio is nevertheless not an estimate of the PPV and to be truly
useful in a practical clinical setting, one would still have to estimate
the relationship between these two values. This could probably be
achieved empirically from the data, as shown in Fig. 2.
Methodological issues inherent to the application of automated
classiﬁcation algorithms in a clinical setting have been reviewed re-
cently (Kloppel et al., 2012). Several sources of misclassiﬁcation
should be speciﬁcally considered here. Despite the relatively large
number of PET scans used to build the RVM classiﬁers, we speculate
that the sample size might still be too low to capture the full variabil-
ity in FDG uptake pattern underlying the clinical heterogeneity of PD
and APS. Imbalanced datasets might be associated with lower classi-
ﬁcation accuracy in the minority classes if this problem is not ade-
quately handled. The approach privileged here was to use stratiﬁed
bootstrap samples in which the number of scans between classes in
the learning sets is balanced across classes (Fig. 1) (Efron and
Tibshirani, 1993). While parkinsonism often manifests asymmetrical-
ly, the laterality of image features was not taken into account for theimage-based classiﬁcation. For instance, one could speculate that bet-
ter classiﬁcation accuracy might be achieved by left–right ﬂipping in-
dividual FDG PET scans so that the cerebral hemisphere contralateral
to the clinically most affected body side is represented on the same
image side in all subjects. This was not performed here because deﬁn-
ing an objective criterion for ﬂipping is not applicable. On the one
hand, asymmetry of parkinsonism is not always clinically obvious in
some APS patients especially in PSP and on the other hand FDG up-
take features can be expressed bilaterally, without apparent asymme-
try such as in PD.
A clinical misdiagnosis at follow-upmight be another source of RVM
misclassiﬁcation but this risk is not equal across the classes under con-
sideration. A deﬁnite diagnosis of PD, MSA, PSP and CBS can only made
post-mortem on the basis of a neuropathological examination, which
was not available here. When the pathological diagnosis is lacking, the
application of clinical diagnostic criteria up to the latest available clini-
cal follow-up as in the present study considerably increases diagnosis
accuracy. Indeed, crude clinical diagnosis accuracy estimates for PD,
MSA and PSP are about 65%, 22% and 17% in the ﬁrst years after symp-
tom onset, respectively (Osaki et al., 2002; Osaki et al., 2004; Rajput et
al., 1991) while, at follow-up, the highest accuracy that can be achieved
using clinical criteria is ~90% for PD, 70–75% forMSA and PSP andmuch
lower for CBS (Hughes et al., 2001; Ling et al., 2010). In this retrospec-
tive study, we acknowledge that the accuracy of the clinical diagnosis
depended heavily on the reliability and completeness of the supplied
clinical picture by the treating neurologists. We have no doubt that
this methodology is appropriate in PD for whom clinical information
was still available on average more than 8 years after PET scanning. In
APSwhohadpoorer prognosis and thus shorter follow-up,we acknowl-
edge that some subtle clinical details may have been missed and we
cannot exclude the possibility that this may have contributed to some
extent to misdiagnosis between APS. Altogether, these data suggests
that a clinical misdiagnosis at follow-up (i.e., incorrect standard of
truth) probably plays a greater role in RVM misclassiﬁcation of APS
than PD scans.
RVM predictions were based on the one-to-one comparison be-
tween the distinctive patterns of resting-state cerebral FDG uptake
(Fig. 1) and a bootstrap resampling procedure from which we derived
standardized maps identifying the most consistent voxel weights the
excess and deﬁcit networks (EN and DN). The relevance maps shown
in Fig. 3 are thus unlikely driven by outliers. By convention in the com-
parisons between PD and APS classes, the EN encompasses brain areas
where FDG uptake levels are relatively preserved in the former as com-
pared with the latter.
These ENs are consistentwith strictly localized decreases in the level
of FDG uptake previously identiﬁed using mass univariate analyses in
MSA (Antonini et al., 1998; Eckert et al., 2005; Eidelberg et al., 1993;
Feng et al., 2008; Ghaemi et al., 2002; Juh et al., 2004; Otsuka et al.,
1997), PSP (Eckert et al., 2005; Juh et al., 2004; Klein et al., 2005) and
CBS (Eckert et al., 2005; Laureys et al., 1999) with respect to PD or an
age-matched normal control population. The ENs in APS also partially
overlap with the topographical distribution of neuropathological
changes identiﬁed using magnetic resonance imaging (MRI) and histo-
pathological studies. For instance, the strong contribution of frontal cor-
tical areas found bymulticlass RVM in the EN of PSP and CBS classes but
not MSA class is in agreement with the ﬁnding that the brains of pa-
tients with PSP and CBS have relatively greater pathology in the frontal
cortex early in the disease course, while this is marginally present in
MSA (Dickson et al., 2010; Schrag et al., 2000;Wenning et al., 1997). Al-
together, this provides support to the biological relevance of the EN
identiﬁed in APS by RVM without any a priori assumption.
The DNs identiﬁed by RVM analyses comparing PD and APS sub-
classes consistently encompass many cortical areas with the notable
exception of the dorsal and medial aspects of caudal frontal lobes,
which are part of the EN (see above). The most consistent areas of
the DN over bootstrap resamplings are the ventral aspects of frontal
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terior cingulate, occipital and lateral aspects of parietal and temporal
cortices (Fig. 3). Decreased FDG uptake in these cortical areas is a con-
sistent ﬁnding in studies comparing non-demented PD patients with
a normal control population using either univariate analyses (Eckert
et al., 2005; Garraux et al., 2011; Hu et al., 2000) or the PCA method
(see above) (Ma et al., 2007). As shown in Fig. 3b, RVM consistently
identiﬁed the occipital cortex in the deﬁcit network of the PD class
as compared with MSA, PSP and CBS classes. This is in agreement
with results obtained using univariate analysis methods that reported
decreased FDG uptake in the occipital cortex as a supportive feature
for PD as compared with APS (Hellwig et al., 2012). However, the pri-
mary site of supraspinal pathology in PD is in the brainstem while
cortical areas are usually not affected by neuropathological abnormal-
ities at least in the ﬁrst years after the initial diagnosis of PD (Halliday
et al., 2008). The pathophysiological basis of this widespread cortical
decrease in FDG uptake in non-demented PD patients is currently
unknown.
All patients were scanned under their usual medications and there
were group differences in L-DOPA equivalent daily doses (LEDD)
(Tomlinson et al., 2010) at the time of FDG PET assessment. The effects
of chronic administration of antiparkinsonian drugs on regional cere-
bral FDG uptake are currently unknown. In one study performed in PD
patients at an advanced disease stage, decreased FDG uptake in the bi-
lateral ventral/orbital frontal cortex and the thalamus was reported
1 h after an acute challenge of orally administered L-DOPA (Berding et
al., 2001). In another study, L-DOPA administered IV was shown to re-
duce FDG uptake in the putamen, thalamus, and cerebellum in patients
with PD (Feigin et al., 2001). To the best of our knowledge, there are no
comparable studies in APS who typically show a poor clinical response
to antiparkinsonian drugs. To the best of our knowledge, there are no
comparable studies on the chronic effects of antiparkinsonian medica-
tions on resting-state FDG uptake pattern assessed using amultivariate
approach. The underlying effects, if any, on RVM classiﬁcation perfor-
mance and relevance maps are unclear.
In conclusion, these novel results show that a multiclass classiﬁca-
tion problem, mimicking a situation encountered in a clinical setting,
can be adequately addressed by an automatic, single step, one-to-one
comparison cerebral FDG uptake patterns using RVM in combination
with bootstrap resampling. The method is fast, fully automatic and
can be easily implemented in a clinical setting. However, additional
methodological milestones should be achieved before the present
methods could be fully transferred to the clinic including pattern val-
idation on larger independent cohorts of incident cases involving a
standardized, prospective data acquisition, optimization of image
preprocessing methods (Merhof et al., 2011) to allow multicenter
studies, and optimization of the RVM analysis on an independent
sample including a reﬁnement of image-based cut off values used
for classiﬁcation (Kriegeskorte et al., 2009).
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.nicl.2013.06.004.
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